Skip to main content

Table 1 Inclusion and exclusion criteria

From: Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects

Inclusion criteria Exclusion criteria
18 years and older Undefined type of diabetes or clinical suspicion of non-type 2 diabetes mellitus
Confirmed diagnosis of type 2 diabetes mellitus at the time of admission Confirmed pancreatic insufficiency, chronic pancreatitis or previous pancreatic surgery
Able to understand study procedures Ongoing steroidal therapy or steroidal therapy in the previous 3 months
Willing to participate in the study and to sign the written informed consent Ongoing calcineurin inhibitor therapy or history of calcineurin inhibitor therapy
  Ongoing statin therapy or statin therapy in the previous month
  Suspected or confirmed pregnancy
  Chronic kidney disease with eGFR below 30 mL/min (according to the CKD-EPI equation)
  Previous non-traumatic lower limb amputation
  Solid organ or marrow transplant recipient
  History or active solid or hematological malignancy
  Acute infectious disease at the time of evaluation or in the previous month
  Chronic liver disease with a functional status, according to the Child–Pugh classification, of B or above
  Hereditary monogenic dyslipidemia (confirmed or suspected)
  Congenital disease of platelet function
  Acquired or congenital thrombocytopenia
  Congenital or acquired hemophilia or coagulation defect
  Congenital or acquired thrombophilia
  Active autoimmune disease